IVAX, 1.875% 15dec2024, USD (Conv.) (FIGI BBG000858MN7, WKN A0D0UG)
国内債券, 転換社債, トレース適格, Senior Unsecured
国内債券, 転換社債, トレース適格, Senior Unsecured
|
IVAX LLC engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. The company offers respiratory drugs primarily for bronchial asthma, including a breath-operated inhaler called BREATHMATICa in the United States; Easi-Breathe in other ...
IVAX LLC engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. The company offers respiratory drugs primarily for bronchial asthma, including a breath-operated inhaler called BREATHMATICa in the United States; Easi-Breathe in other countries; and a dry powder inhaler, as well as metered-dose inhalers. The company was founded in 1987 and is headquartered in Weston, Florida. As of January 26, 2006 IVAX LLC operates as a subsidiary of Teva Pharmaceutical Industries Limited.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡